Results 121 to 130 of about 7,656 (201)

Dual targeting NG2 and GD3A using Mab-Zap immunotoxin results in reduced glioma cell viability in vitro [PDF]

, 2015
Ashkan, Keyoumars, Butt, Arthur M., Fillmore, Helen L., Higgins, Samantha C., Pilkington, Geoffrey J.   +4 more
core   +1 more source

The use of chimeric bacterial and plant protein toxins for targeted chemotherapy [PDF]

, 1905
Alouf, J.E.
core   +1 more source

Design and Characterization of Ricin Based Immunotoxins Against EPHA2 Receptor for Breast Cancer Therapy: An In-Silico Study. [PDF]

Iran J Pharm Res
Faraz A, Amani J, Arbabian S, Zare Karizi S, Bikhof Torbati M.   +4 more
europepmc   +1 more source

Assessment of the Effects of Single-Domain Anti-Idiotypic Distribution Enhancers on the Disposition of Trastuzumab and on the Efficacy of a PE24-Trastuzumab Immunotoxin. [PDF]

Cancers (Basel)
Chen P, Zhang Y, Bordeau BM, Balthasar JP.   +3 more
europepmc   +1 more source

Evaluation of the Safety of A Novel Anti-HER2 Immunotoxin Containing Modified Fragment of <i>Pseudomonas</i> Exotoxin in BALB/C Mice. [PDF]

Iran J Biotechnol
Saadatkhah F, Hajhashemi V, Naimi A, Akbari V, Kolahdoozan M.   +4 more
europepmc   +1 more source

Bringing enzymes to the proximity party. [PDF]

RSC Chem Biol, 2023
Tender GS, Bertozzi CR.
europepmc   +1 more source

Clinically approved immunotoxins targeting hematological cancers: "the best of both worlds". [PDF]

Front Pharmacol
Rashad Y, Alt EU, Izadpanah R, Qin X, Braun SE.   +4 more
europepmc   +1 more source

Enhanced cytotoxicity of a Pseudomonas Exotoxin A based immunotoxin against prostate cancer by addition of the endosomal escape enhancer SO1861. [PDF]

Front Pharmacol, 2023
Masilamani AP, Huber N, Nagl C, Dettmer-Monaco V, Monaco G, Wolf I, Schultze-Seemann S, Taromi S, Gratzke C, Fuchs H, Wolf P.   +10 more
europepmc   +1 more source

Photochemical enhancement of PD-L1-SAP immunotoxin efficacy in non-small cell lung cancer cell lines. [PDF]

Front Immunol
Kozlíková M, Aukrust IKF, Rohlíčková M, Macháček M, Berg K, Weyergang A, Selbo PK.   +6 more
europepmc   +1 more source

A new treatment for canine B-cell lymphoma based on a recombinant single-domain antibody immunotoxin derived from <i>Pseudomonas aeruginosa</i> exotoxin A. [PDF]

Front Vet Sci
André AS, Dias JNR, Moutinho I, Loureiro J, Leonardo A, Nogueira S, Marimon RP, Bule P, Correia J, Malhó R, Gano L, Correia JDG, Gil S, Gonçalves J, Pastan I, Tavares L, Aires-da-Silva F.   +16 more
europepmc   +1 more source